Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002882
PubMed Identifier: 31415563
Publication URI: http://europepmc.org/abstract/MED/31415563
Type: Journal Article/Review
Volume: 16
Parent Publication: PLoS medicine
Issue: 8
ISSN: 1549-1277